Digestive Diseases and Sciences

, Volume 47, Issue 8, pp 1705–1715

Resource Utilization Associated with Irritable Bowel Syndrome in the United States: 1987–1997

  • Ya-Chen Tina Shih
  • Victoria E. Barghout
  • Robert S. Sandler
  • Priti Jhingran
  • Medha Sasane
  • Suzanne Cook
  • David C. Gibbons
  • Michael Halpern
Article

DOI: 10.1023/A:1016471923384

Cite this article as:
Shih, YC.T., Barghout, V.E., Sandler, R.S. et al. Dig Dis Sci (2002) 47: 1705. doi:10.1023/A:1016471923384

Abstract

This study uses national databases to examine the impact of irritable bowel syndrome (IBS) on resource utilization in the United States. Approximately 1.5–2.7 million physician visits (599–1043 per 100,000) yearly were related to IBS, with 45.3% seen by gastroenterologists, and 89% prescribed medications. Rates of physician visits by women were approximately 2.4–3.3 times higher than that for men. The average number of medication prescribed per visit was 1.83. Approximately 89% of the visits were prescribed with medications. The rate of hospitalization (5.1 per 100,000 in 1997) decreased by 60% and length of stay decreased from 5.5 to 3.1 days in the past decade. The average charges of IBS-related hospitalization were US$7,882. Our study found an apparent decreasing trend of IBS-related hospitalizations and no marked increase in office consultations in the past decade. However, a better case identification criterion is necessary to estimate the true disease burden.

irritable bowel syndromeresource utilizationNational Ambulatory Medical Care SurveyNational Disease and Therapeutic IndexNational Hospital Discharge SurveyNational Inpatient SampleHealthcare Cost and Utilization Project

Copyright information

© Plenum Publishing Corporation 2002

Authors and Affiliations

  • Ya-Chen Tina Shih
    • 1
  • Victoria E. Barghout
    • 2
  • Robert S. Sandler
    • 3
  • Priti Jhingran
    • 4
  • Medha Sasane
    • 5
  • Suzanne Cook
    • 4
  • David C. Gibbons
    • 4
  • Michael Halpern
    • 6
  1. 1.MEDTAP International Inc.BethesdaUSA
  2. 2.Novartis Pharmaceutical CorporationEast HanoverUSA
  3. 3.University of North CarolinaChapel HillUSA
  4. 4.Research Triangle ParkGlaxoSmithKline Inc., U.S. Medical Affairs Health OutcomesNorth CarolinaUSA
  5. 5.Research Triangle ParkStrategic Outcomes Services of Care Science Inc.North CarolinaUSA
  6. 6.Exponent Inc.AlexandriaUSA